Search Within

Jedd D Wolchok

  1. "Stephane Pourpe"
Formats
  1. Meeting Abstract (9)
  2. Journal Article (3)
Groups
  1. Department of Medicine (12)
  2. GSK Faculty (12)
  3. Melanoma and Immunotherapeutics Service (12)
  4. Solid Tumor Oncology Division (12)
  5. Sloan Kettering Institute Postdocs (11)
  6. MSK Grad Students (5)

More Groups

People
  1. Stephane Pourpe (12)
  2. Taha Merghoub (12)
  3. Mathieu Gigoux (7)
  4. Cailian Liu (6)
  5. Levi Mark Mangarin (6)
  6. Roberta Zappasodi (6)

More People

Years
  1. 2022 (2)
  2. 2020 (4)
  3. 2019 (1)
  4. 2018 (4)
  5. 2017 (1)
Publications
  1. Journal for ImmunoTherapy of Cancer (3)
  2. Cancer Research (2)
  3. Journal of Immunology (2)
  4. Cancer Immunology Research (1)
  5. Cell (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (3)
  2. Biomed Central Ltd (3)
  3. The American Association of Immunologists, Inc (2)
  4. American Association for the Advancement of Science (1)
  5. American Society of Clinical Oncology (1)
  6. Cell Press (1)

More Publishers

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Potential role of CD47 in T cell exhaustion program
    Meeting Abstract

    Weng, C. H.; Samaan, F.; Budhu, S.; Mangarin, L.; Monette, S.; Liu, C.; Pourpe, S.; Hamadene, L.; Zhong, H.; Yang, X.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine
    Journal Article

    Gigoux, M.; HolmstroĢˆm, M. O.; Zappasodi, R.; Park, J. J.; Pourpe, S.; Bozkus, C. C.; Mangarin, L. M. B.; Redmond, D.; Verma, S.; Schad, S.; more...
    Science Translational Medicine (2022)

    Fulltext@MSK | Save
  • MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms is countered by heteroclitic peptide cancer vaccination
    Meeting Abstract

    Gigoux, M.; Zappasodi, R.; Park, J.; Pourpe, S.; Ghosh, A.; Bozkus, C. C.; Mangarin, L.; Redmond, D.; Verma, S.; Schad, S.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Heteroclitic peptide cancer vaccine counters MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms
    Meeting Abstract

    Gigoux, M.; Zappasodi, R.; Park, J. J.; Pourpe, S.; Ghosh, A.; Bozkus, C. C.; Mangarin, L. M. B.; Redmond, D.; Verma, S.; Schad, S.; more...
    Journal of Immunology (2020)

    Fulltext@MSK | Save
  • Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine
    Journal Article

    Campesato, L. F.; Budhu, S.; Tchaicha, J.; Weng, C. H.; Gigoux, M.; Cohen, I. J.; Redmond, D.; Mangarin, L.; Pourpe, S.; Liu, C.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save
  • Blockade of AHR activation by IDO/TDO-derived kynurenine restricts cancer immune suppression
    Meeting Abstract

    Campesato, L. F.; Budhu, S.; Gigoux, M.; Tchaicha, J.; Pourpe, S.; Liu, C.; Zamarin, D.; Manfredi, M. G.; McGovern, K.; Wolchok, J. D.; more...
    Cancer Immunology Research (2020)

    Fulltext@MSK | Save
  • Blockade of IDO/TDO downstream effectors restricts a Treg-macrophage suppressive axis and resistance to anti-PD-1 therapy
    Meeting Abstract

    Campesato, L.; Budhu, S.; Tchaicha, J.; Gigoux, M.; Cohen, I.; Mangarin, L.; Redmond, D.; Pourpe, S.; Liu, C.; Zappasodi, R.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Exploring effects of MEK inhibition in tumor microenvironment in non-small cell lung cancer (NSCLC) pre-clinical models
    Meeting Abstract

    Silk, T.; Choi, H.; Deng, J.; Pourpe, S.; Wong, K. K.; Merghoub, T.; Wolchok, J. D.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Defined factors overcome T-cell exhaustion via abscopal effect
    Meeting Abstract

    Khalil, D.; Campesato, L. F.; Budhu, S.; Li, Y.; Jones, C.; Suek, N.; Liu, C.; Gasmi, B.; Giese, R.; Pourpe, S.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Interaction between Kynurenine and the AhR is an effector mechanism of tumor immunosuppression and represents a potential immunotherapy target
    Meeting Abstract

    Campesato, L. F.; Budhu, S.; Tchaicha, J.; Pourpe, S.; Liu, C.; Manfredi, M. G.; McGovern, K.; Wolchok, J. D.; Merghoub, T.
    Journal of Immunology (2018)

    Fulltext@MSK | Save